Soligenix (Warrant)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SNGXW and buy or sell other stocks, ETFs, and their options commission-free!

About SNGXW

Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. 

CEO
Christopher J. Schaber, PhD
CEOChristopher J. Schaber, PhD
Employees
Employees
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1987
Founded1987
Employees
Employees

SNGXW Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
52 Week high
52 Week low
52 Week low

SNGXW News

Seeking Alpha 7d
Soligenix GAAP EPS of -$0.12 beats by $0.10

Soligenix had no revenue for the quarter ended June 30, 2026 and 2025, respectively. Soligenix's net loss was $2.0 million, or ($0.12) per share, for the quart...

Soligenix GAAP EPS of -$0.12 beats by $0.10
Barchart 7d
Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results - Barchart.com

...

Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results - Barchart.com

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.